FIELD medicine. ^ SUBSTANCE invention refers to medicine specifically to anaesthesiology and blood-saving techniques in anaesthesiology and resuscitation science and can be used as anaesthetic management within adrenalectomy caused by epinephros pheochromocytoma. For this purpose operation is preceded with complex patient examination. Preanesthetic medication applied one day before and in the morning prior to operation implies introduction of tableted phenozepam dosed 0.0005-0.001 g and 30 min b...

FIELD medicine narcology. ^ SUBSTANCE method involves alternating comatose therapy and electroshock therapy every other day. In day carrying out the comatose therapy eserine ointment is placed in conjunctival sacs to patient and in 30 min 2-2.5 mg scopolamine hydrobromide solution is administrated as its 0.5% solution. Then in 3-5 h of comatose state patient is recovered from coma and 15-30 mg of physostigmine 6 g of pyracetam 7.5 g of magnesium sulfate and 400 ml of sodium hypochlorite are admi...

The present invention describes an injectable and stable pharmaceutical composition of thiopental ready-to-use whose can be packed in glass ampoules for single doses or multidose vials for multiple doses. A method for stabilizing an aqueous solution of thiopental and the use of thiopental to make a medicament are also described.

The present invention describes an injectable and stable pharmaceutical composition of thiopental ready-to-use whose can be packed in glass ampoules for single doses or multidose vials for multiple doses. A method for stabilizing an aqueous solution of thiopental and the use of thiopental to make a medicament are also described.

The invention comprises a compound of the formula: and its pharmaceutically acceptable salts and the preparation thereof by fusing b -methyl-b -isopropyl-glutaric acid with urea and recovering from the fusion product the glutarimide which if desired is converted into a pharmaceutically acceptable salt. b -Methyl-b -isopropyl-glutaric acid is made by hydrolysis of b -methyl-b -isopropyl-a a 1-dicyanoglutarimide which is formed from methyl isopropyl ketone and ethyl cyanoacetate. Specification ...